Sleep Disorder Market – By Disorder Type, By Product, By End Use – Global Forecast, 2025 to 2034

Sleep Disorder Market Size

The global sleep disorder market size was valued at USD 27.6 billion in 2024 and is expected to exhibit growth at a CAGR of 10.1% from 2025 to 2034. High market growth can be attributed to the growing prevalence of sleep disorders, rising demand for portable, efficient, and superior devices for sleep disorders, and increasing awareness regarding sleep disorders, among other contributing factors.
 

The increasing prevalence of sleep disorders, including insomnia, sleep apnea, restless leg syndrome, and narcolepsy, is a major growth driver in the sleep disorder market. Modern lifestyles characterized by high-stress levels, irregular work hours, and a surge in digital device usage have significantly impacted sleep health, leading to a rise in cases of sleep-related issues. For instance, according to the Centers for Disease Control and Prevention (CDC), approximately 70 million Americans suffer from chronic sleep problems. This widespread prevalence is fueling demand for a variety of treatment options, ranging from sleep aids and medication to advanced diagnostic tools and therapeutic devices, as healthcare providers work to address the growing burden of sleep disorders.
 

Additionally, public awareness surrounding the importance of sleep for overall health has grown, with increased recognition that poor sleep is linked to various chronic health issues, such as cardiovascular disease, obesity, and mental health conditions. Health campaigns and educational initiatives emphasize the importance of addressing sleep disorders and encouraging individuals to seek professional care. This rising awareness is translating into higher market demand for both diagnostic services and a range of treatment options, from cognitive behavioral therapy (CBT) to continuous positive airway pressure (CPAP) devices.
 

Sleep disorder is a medical condition in which the patient has difficulty maintaining sleep. The market study includes different types of disorders such as insomnia, narcolepsy, and sleep apnea, along with their diagnostic and therapeutic devices.
 

Sleep Disorder Market Trends

Technological advancements in sleep tech devices are significantly propelling growth in the market. Innovations in this area include wearable devices, smart home-integrated sleep monitors, and sophisticated diagnostic and therapeutic equipment, all designed to improve sleep quality and address sleep disorders.
 

• Wearable devices, such as smartwatches and fitness bands, now come equipped with advanced sensors that can track sleep patterns, stages, and duration. By providing continuous, real-time data on an individual’s sleep cycles, these devices allow users and healthcare providers to gain valuable insights into sleep behaviors and potential disorders. The convenience and accessibility of wearables make them particularly appealing for early detection and self-monitoring, contributing to rising consumer demand and expanding the market for sleep disorder solutions.
   
• Additionally, recent advancements in diagnostic technologies, including portable sleep monitors and home sleep testing (HST) devices, are revolutionizing the diagnosis of sleep disorders. Previously, sleep studies required an overnight stay at a sleep clinic; however, portable diagnostic devices now allow patients to be monitored from the comfort of their homes. These advanced diagnostic tools are equipped with sensors that track respiratory rate, oxygen levels, and brain activity, providing comprehensive data for accurate diagnoses of sleep disorders like sleep apnea. This shift toward at-home diagnostics has expanded the market by making sleep disorder evaluations more accessible and convenient.
   

Sleep Disorder Market Analysis

Based on disorder type, the market is classified into sleep apnea, restless legs syndrome (RLS), insomnia, narcolepsy, and other disorders. The sleep apnea segment generated the highest revenue of USD 13.2 billion in 2024.
 

• Sleep apnea affects a substantial portion of the population, with obstructive sleep apnea (OSA) being the most widespread form. For instance, according to the National Institutes of Health (NIH), approximately 25 million adults in the U.S. suffer from OSA. The condition is especially prevalent among aging populations and individuals with obesity or other risk factors.
   
• As awareness of sleep apnea grows, more individuals are seeking diagnosis and treatment, contributing to the segment’s market dominance. Moreover, public health campaigns and efforts by healthcare providers have further highlighted the importance of addressing sleep apnea, increasing demand for related products and services.
   
• Furthermore, the growing support for sleep apnea diagnosis and treatment through insurance coverage and reimbursement has made therapies more affordable and accessible. In many regions, health insurance providers now cover the cost of sleep studies and CPAP devices, encouraging more individuals to seek treatment. This financial support is particularly impactful for the sleep apnea segment, as it reduces barriers to treatment, expands patient access, and drives market growth.
   

Based on product, the sleep disorder market is classified into diagnostics and therapeutics. The therapeutics segment is expected to drive business growth and expand at a CAGR of 10.5%, reaching over USD 47.2 billion by 2034.
 

• Technological advancements in therapeutic devices, particularly for sleep apnea, have significantly contributed to the growth of the therapeutics segment. Sleep apnea devices like CPAP and BiPAP (Bilevel Positive Airway Pressure) machines are considered gold-standard treatments for sleep apnea, providing continuous airflow to keep airways open during sleep. Newer, more compact, and comfortable CPAP devices, coupled with digital monitoring features, have increased patient adherence to therapy, enhancing treatment effectiveness and driving the segment’s growth.
   
• Moreover, insurance and reimbursement policies covering sleep disorder therapies, including both medications and devices, have also spurred market growth. In many regions, insurance providers now support the cost of sleep studies, sleep medications, and devices such as CPAP machines, reducing the financial burden on patients. This support has made therapies more affordable and accessible, encouraging more patients to seek treatment and driving up the therapeutics segment’s market share.
   

Based on end use, the sleep disorder market is segmented into home care settings and individuals, and sleep laboratories and hospitals. The home care settings and individuals segment dominated the market in 2024 and is anticipated to reach USD 43.2 billion by the end of the forecast period.
 

• Many individuals now prioritize the convenience of managing sleep disorders in a home environment over frequent visits to sleep clinics or hospitals. With a variety of effective at-home treatments, such as over-the-counter sleep aids, wearable sleep trackers, and CPAP devices, individuals can monitor and manage their sleep health from home. This shift toward self-management has significantly expanded the market for sleep disorder products designed for home care, cementing the segment’s market dominance.
   
• Innovations in home-based diagnostic and therapeutic devices have made it easier for individuals to track their sleep patterns and treat conditions like sleep apnea. Portable sleep apnea monitors, wearable sleep trackers, and home sleep testing kits allow for comprehensive sleep assessments outside of clinical settings.
   
• Additionally, CPAP devices and other airway therapy products designed for in-home use have been widely adopted by individuals with sleep apnea. These advancements enable more accurate diagnoses and effective treatment in home settings, contributing to this segment’s market leadership.
   

North America sleep disorder market accounted for USD 10.6 billion in market revenue in 2024 and is anticipated to grow at a CAGR of 9.6% between the 2025 – 2034 period.
 

• The region has a large population affected by conditions such as sleep apnea, insomnia, and restless leg syndrome, leading to strong demand for diagnostic and therapeutic solutions.
   
• Additionally, widespread access to specialized sleep clinics and high adoption of innovative sleep technologies, like CPAP devices and wearable sleep trackers, support market growth.
   
• Public awareness campaigns, insurance coverage for sleep disorder treatments, and an aging population further strengthen North America’s leading position in this market.
   

France sleep disorder market is projected to grow remarkably in the coming years.
 

• The French population has shown rising concern about sleep health, leading to greater demand for treatments and technologies that address common conditions such as insomnia and sleep apnea.
   
• The presence of advanced sleep laboratories and skilled sleep specialists supports the diagnosis and treatment of sleep disorders, while government health initiatives help raise awareness and accessibility.
   
• Additionally, reimbursement policies for diagnostic tests and sleep apnea therapies encourage more individuals to seek medical intervention, driving market expansion.
   

Japan holds a dominant position in the Asia Pacific sleep disorder market.
 

• In recent years, technological advancements in wearable sleep monitoring devices and home-use CPAP devices have gained traction, enabling individuals to manage sleep health independently.
   
• Japan’s commitment to preventive healthcare and public health initiatives to raise awareness about the importance of quality sleep has further propelled market growth in the region.
   

Sleep Disorder Market Share

The market is highly competitive, with key players including large multinationals like ResMed Inc., Natus Medical Inc., and Teleflex Inc., which lead in innovation and extensive product portfolios. Regional companies and new entrants, particularly from APAC, are intensifying competition with affordable, sleep disorder products tailored for local markets. The market sees frequent technological advancements, such as advanced design, enhanced comfort, and precision and data tracking systems, which drive ongoing product development. Strategic partnerships, mergers, and acquisitions are also common as companies seek to expand market reach and enhance their technological capabilities.
 

Sleep Disorder Market Companies

Prominent players operating in the sleep disorder industry include:

• Apple Inc.
• Asahi Kasei Corporation
• BMC Medical
• Cadwell Laboratories
• Drive DeVilbiss International
• Fisher & Paykel Healthcare
• Fitbit I
• Koninklijke Philips N.V.
• LivaNova
• Natus Medical
• Nihon Kohden
• Oura Health
• ResMed
• Sleep Shepherd
• Sleepace
• Teleflex
• WEINMANN Emergency Medical Technology GmbH + Co. KG
• Withings
• Xiaomi
   

Sleep Disorder Industry News:

• In February 2024, ResMed announced the launch of its new bi-level sleep apnea device as a CPAP alternative. This product may help the company strengthen its product portfolio and enhance its customer base.
   
• In September 2024, the U.S. Food and Drug Administration (FDA) approved Apple’s new sleep apnea detection feature. This approval will allow Apple to offer the feature on Apple Watch Series 9, Series 10, and Ultra 2, enhancing its product offering and gaining a competitive edge over its peers.
   

The sleep disorder market research report includes in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Disorder Type

• Sleep apnea
  • Obstructive sleep apnea
  • Central sleep apnea/Complex sleep apnea
  • Complex sleep apnea
• Restless legs syndrome (RLS)
• Insomnia
• Narcolepsy
• Other disorders

Market, By Product

• Diagnostics
  • Polysomnography (PSG) device
    • Ambulatory PSG devices
    • Clinical PSG devices
  • Home sleep testing (HST) devices
    • Type 2
    • Type 3
    • Type 4
  • Actigraphy systems
  • Sleep screening devices
  • Pulse oximeter
  • Respiratory polygraph
  • Wearables
    • Smart watches and bands
    • Other wearables
• Therapeutics
  • Cognitive behavioral therapy
  • Therapeutic devices 
    • Positive airway pressure (PAP) devices
      • Continuous positive airway pressure (CPAP) devices
      • Bilevel positive airway pressure (BiPAP) devices
      • Automatic positive airway pressure (APAP) devices
    • Oral appliances
      • Mandibular advancement devices
      • Tongue-retaining devices
      • Rapid maxillary expansion
      • Mouth guards
    • Adaptive servo-ventilation (ASV)
    • Airway clearance system
    • Oxygen devices
    • Other therapeutic devices

Market, By End Use

• Home care settings and individuals
• Sleep laboratories and hospitals

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE